vs
Bloom Energy Corp（BE）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Bloom Energy Corp的季度营收约是Pediatrix Medical Group, Inc.的1.5倍（$751.1M vs $493.8M），Bloom Energy Corp净利率更高（9.4% vs 6.8%，领先2.6%），Pediatrix Medical Group, Inc.同比增速更快（-1.7% vs -3.4%），过去两年Bloom Energy Corp的营收复合增速更高（51.7% vs -0.1%）
Bloom Energy Corp是一家能源技术企业，由印裔美国工程师、发明家、企业家KR·斯里达尔创立，他同时担任公司董事长兼首席执行官。斯里达尔此前曾任亚利桑那大学航空航天与机械工程教授、空间技术实验室主任，曾为NASA提供顾问服务，现为美国国家工程院院士。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
BE vs MD — 直观对比
营收规模更大
BE
是对方的1.5倍
$493.8M
营收增速更快
MD
高出1.7%
-3.4%
净利率更高
BE
高出2.6%
6.8%
两年增速更快
BE
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $751.1M | $493.8M |
| 净利润 | $70.7M | $33.7M |
| 毛利率 | 30.0% | — |
| 营业利润率 | 17.3% | 9.9% |
| 净利率 | 9.4% | 6.8% |
| 营收同比 | -3.4% | -1.7% |
| 净利润同比 | 396.7% | 10.5% |
| 每股收益（稀释后） | $0.44 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEMD
| Q1 26 | $751.1M | — | ||
| Q4 25 | $772.8M | $493.8M | ||
| Q3 25 | $513.3M | $492.9M | ||
| Q2 25 | $396.3M | $468.8M | ||
| Q1 25 | $319.3M | $458.4M | ||
| Q4 24 | $567.0M | $502.4M | ||
| Q3 24 | $321.8M | $511.2M | ||
| Q2 24 | $326.5M | $504.3M |
净利润BEMD
| Q1 26 | $70.7M | — | ||
| Q4 25 | $1.4M | $33.7M | ||
| Q3 25 | $-23.0M | $71.7M | ||
| Q2 25 | $-42.2M | $39.3M | ||
| Q1 25 | $-23.4M | $20.7M | ||
| Q4 24 | $105.2M | $30.5M | ||
| Q3 24 | $-14.6M | $19.4M | ||
| Q2 24 | $-61.2M | $-153.0M |
毛利率BEMD
| Q1 26 | 30.0% | — | ||
| Q4 25 | 31.0% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 27.0% | — | ||
| Q1 25 | 27.8% | — | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 21.0% | — |
营业利润率BEMD
| Q1 26 | 17.3% | — | ||
| Q4 25 | 11.3% | 9.9% | ||
| Q3 25 | 1.5% | 13.8% | ||
| Q2 25 | -0.9% | 12.8% | ||
| Q1 25 | -6.0% | 7.0% | ||
| Q4 24 | 18.5% | 7.8% | ||
| Q3 24 | -3.0% | 6.6% | ||
| Q2 24 | -7.1% | -31.3% |
净利率BEMD
| Q1 26 | 9.4% | — | ||
| Q4 25 | 0.2% | 6.8% | ||
| Q3 25 | -4.5% | 14.5% | ||
| Q2 25 | -10.6% | 8.4% | ||
| Q1 25 | -7.3% | 4.5% | ||
| Q4 24 | 18.5% | 6.1% | ||
| Q3 24 | -4.5% | 3.8% | ||
| Q2 24 | -18.7% | -30.3% |
每股收益（稀释后）BEMD
| Q1 26 | $0.44 | — | ||
| Q4 25 | $99.91 | $0.40 | ||
| Q3 25 | $-100.00 | $0.84 | ||
| Q2 25 | $-0.18 | $0.46 | ||
| Q1 25 | $-0.10 | $0.24 | ||
| Q4 24 | $0.45 | $0.37 | ||
| Q3 24 | $-0.06 | $0.23 | ||
| Q2 24 | $-0.27 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $375.2M |
| 总债务越低越好 | — | $570.5M |
| 股东权益账面价值 | $948.0K | $865.9M |
| 总资产 | $4.7B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资BEMD
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $375.2M | ||
| Q3 25 | $595.1M | $340.1M | ||
| Q2 25 | $574.8M | $224.7M | ||
| Q1 25 | $794.8M | $99.0M | ||
| Q4 24 | $802.9M | $229.9M | ||
| Q3 24 | $495.7M | $103.8M | ||
| Q2 24 | $581.7M | $19.4M |
总债务BEMD
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $570.5M | ||
| Q3 25 | $1.1B | $577.2M | ||
| Q2 25 | $1.1B | $583.9M | ||
| Q1 25 | $1.1B | $590.5M | ||
| Q4 24 | $1.1B | $597.1M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
股东权益BEMD
| Q1 26 | $948.0K | — | ||
| Q4 25 | $768.6M | $865.9M | ||
| Q3 25 | $653.1M | $890.7M | ||
| Q2 25 | $594.6M | $833.8M | ||
| Q1 25 | $578.3M | $789.2M | ||
| Q4 24 | $562.5M | $764.9M | ||
| Q3 24 | $430.9M | $732.5M | ||
| Q2 24 | $423.3M | $706.5M |
总资产BEMD
| Q1 26 | $4.7B | — | ||
| Q4 25 | $4.4B | $2.2B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.7B | $2.2B | ||
| Q3 24 | $2.6B | $2.1B | ||
| Q2 24 | $2.5B | $2.0B |
负债/权益比BEMD
| Q1 26 | — | — | ||
| Q4 25 | 3.41× | 0.66× | ||
| Q3 25 | 1.73× | 0.65× | ||
| Q2 25 | 1.91× | 0.70× | ||
| Q1 25 | 1.96× | 0.75× | ||
| Q4 24 | 2.01× | 0.78× | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 2.66× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BEMD
| Q1 26 | — | — | ||
| Q4 25 | $418.1M | $114.1M | ||
| Q3 25 | $19.7M | $137.3M | ||
| Q2 25 | $-213.1M | $137.2M | ||
| Q1 25 | $-110.7M | $-117.5M | ||
| Q4 24 | $484.2M | $133.0M | ||
| Q3 24 | $-69.5M | $91.8M | ||
| Q2 24 | $-175.5M | $107.0M |
自由现金流BEMD
| Q1 26 | — | — | ||
| Q4 25 | $395.1M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $-220.4M | — | ||
| Q1 25 | $-124.9M | — | ||
| Q4 24 | $473.1M | — | ||
| Q3 24 | $-83.8M | — | ||
| Q2 24 | $-187.5M | — |
自由现金流率BEMD
| Q1 26 | — | — | ||
| Q4 25 | 51.1% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | -55.6% | — | ||
| Q1 25 | -39.1% | — | ||
| Q4 24 | 83.4% | — | ||
| Q3 24 | -26.0% | — | ||
| Q2 24 | -57.4% | — |
资本支出强度BEMD
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.7% | — |
现金转化率BEMD
| Q1 26 | — | — | ||
| Q4 25 | 293.18× | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 4.60× | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BE
| Product | $653.3M | 87% |
| Service | $61.9M | 8% |
| Installation | $25.9M | 3% |
| Electricity | $9.9M | 1% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
